NCT06290232View on ClinicalTrials.gov

Fetoscopic Laser Photocoagulation in Management of Vasa Previa

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 1, 2027

Study Completion Date

March 31, 2028

Conditions
Vasa PreviaPregnancy ComplicationsMaternal; ProcedureIn Utero Procedure Affecting Fetus or Newborn
Interventions
DEVICE

Fetoscopic Laser Photocoagulation

Pregnant patients diagnosed with type II vasa previa will undergo fetoscopic laser photocoagulation of the involved fetal vessels. FLP will be performed laparoscopically using a fetoscope (tiny telescope) and a laser device inside of the womb. This procedure will be completed at 30w0d to 32w6d gestational age.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT06290232 - Fetoscopic Laser Photocoagulation in Management of Vasa Previa | Biotech Hunter | Biotech Hunter